1. Home
  2. DOMO vs RCEL Comparison

DOMO vs RCEL Comparison

Compare DOMO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • RCEL
  • Stock Information
  • Founded
  • DOMO 2010
  • RCEL 2020
  • Country
  • DOMO United States
  • RCEL United States
  • Employees
  • DOMO N/A
  • RCEL N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • RCEL Medical/Dental Instruments
  • Sector
  • DOMO Technology
  • RCEL Health Care
  • Exchange
  • DOMO Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • DOMO 286.1M
  • RCEL 308.6M
  • IPO Year
  • DOMO 2018
  • RCEL N/A
  • Fundamental
  • Price
  • DOMO $7.09
  • RCEL $12.79
  • Analyst Decision
  • DOMO Hold
  • RCEL Buy
  • Analyst Count
  • DOMO 5
  • RCEL 4
  • Target Price
  • DOMO $10.10
  • RCEL $19.33
  • AVG Volume (30 Days)
  • DOMO 416.4K
  • RCEL 117.4K
  • Earning Date
  • DOMO 12-05-2024
  • RCEL 02-20-2025
  • Dividend Yield
  • DOMO N/A
  • RCEL N/A
  • EPS Growth
  • DOMO N/A
  • RCEL N/A
  • EPS
  • DOMO N/A
  • RCEL N/A
  • Revenue
  • DOMO $318,458,000.00
  • RCEL $60,040,000.00
  • Revenue This Year
  • DOMO $0.94
  • RCEL $40.34
  • Revenue Next Year
  • DOMO N/A
  • RCEL $52.79
  • P/E Ratio
  • DOMO N/A
  • RCEL N/A
  • Revenue Growth
  • DOMO 0.01
  • RCEL 32.24
  • 52 Week Low
  • DOMO $6.11
  • RCEL $7.51
  • 52 Week High
  • DOMO $12.23
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 36.29
  • RCEL 52.40
  • Support Level
  • DOMO $7.05
  • RCEL $12.64
  • Resistance Level
  • DOMO $7.39
  • RCEL $13.95
  • Average True Range (ATR)
  • DOMO 0.33
  • RCEL 0.72
  • MACD
  • DOMO -0.03
  • RCEL 0.02
  • Stochastic Oscillator
  • DOMO 16.83
  • RCEL 56.23

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: